A federal judge has allowed Corepharma LLC to seek a declaratory judgment that its application to make a generic version of the anti-seizure drug Carbatrol does not infringe Shire Laboratories Inc.'s patent, even though Shire has agreed not to sue over that patent.
The details can be read here.
No comments:
Post a Comment